<DOC>
	<DOCNO>NCT00235157</DOCNO>
	<brief_summary>The primary objective study compare safety performance Palmaz Genesisâ„¢ balloon expandable stent , without sirolimus coat treatment renal artery stenosis , measure 6 month follow via angiography .</brief_summary>
	<brief_title>A Comparison Coated Uncoated Stents Renal Artery Treatment .</brief_title>
	<detailed_description>Multi-center , prospective , control , non-randomized investigational feasibility study . One hundred ( 100 ) patient de novo restenotic renal artery lesion consist &gt; = 50 % stenosis reference vessel &gt; = 4.0 &lt; = 8.0 mm diameter sequentially include , 50 without sirolimus coating , follow 50 sirolimus coat Palmaz GenesisTM . Patients follow 24 month post-procedure , patient clinical assessment discharge , 1,6 , 12 24 month . This study conduct twelve investigational site . It anticipate total length time require complete study 46 month .</detailed_description>
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Clinical indication renal artery revascularization atherosclerotic renal artery stenosis &gt; =50 % measure operator estimate original vessel diameter , base healthy vessel segment contralateral side . 2 . The reference vessel renal artery must &gt; = 4mm &lt; = 8 mm visual estimate . 3 . The patient must baseline serum creatinine &lt; = 5.0 mg/dl . 1 . Total occlusion renal artery . 2 . Lesions would require 2 stent . 3 . Lesions artery transplant bypassed kidney . 4 . Abdominal aortic aneurysm &gt; 4.0 cm diameter . 5 . Patients ASA classification &gt; =4 .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>